Vähä-Koskela Markus J V, Heikkilä Jari E, Hinkkanen Ari E
Abo Akademi University, Department of Biochemistry and Pharmacy and Turku Immunology Centre, Turku, Finland.
Cancer Lett. 2007 Sep 8;254(2):178-216. doi: 10.1016/j.canlet.2007.02.002. Epub 2007 Mar 23.
Oncolytic virotherapy is a promising form of gene therapy for cancer, employing nature's own agents to find and destroy malignant cells. The purpose of this review is to provide an introduction to this very topical field of research and to point out some of the current observations, insights and ideas circulating in the literature. We have strived to acknowledge as many different oncolytic viruses as possible to give a broader picture of targeting cancer using viruses. Some of the newest additions to the panel of oncolytic viruses include the avian adenovirus, foamy virus, myxoma virus, yaba-like disease virus, echovirus type 1, bovine herpesvirus 4, Saimiri virus, feline panleukopenia virus, Sendai virus and the non-human coronaviruses. Although promising, virotherapy still faces many obstacles that need to be addressed, including the emergence of virus-resistant tumor cells.
溶瘤病毒疗法是一种很有前景的癌症基因治疗形式,它利用自然界自身的媒介来寻找并摧毁恶性细胞。本综述的目的是介绍这个非常热门的研究领域,并指出文献中目前流传的一些观察结果、见解和观点。我们努力提及尽可能多不同的溶瘤病毒,以便更全面地呈现利用病毒靶向癌症的情况。溶瘤病毒组中的一些最新成员包括禽腺病毒、泡沫病毒、黏液瘤病毒、雅巴样疾病病毒、1型艾柯病毒、牛疱疹病毒4、松鼠猴病毒、猫泛白细胞减少症病毒、仙台病毒和非人类冠状病毒。尽管前景广阔,但病毒疗法仍面临许多需要解决的障碍,包括病毒抗性肿瘤细胞的出现。